Menu
Fechar
hrs4r
Quiero donar
Firma
HELENA PLA-JUHER
Posición
Investigador/a Post-doctoral – R2
Investigadores/as Post-doctorales – R2
Projectes
Publicacions

Projectes

Oncología de Precisión de Girona

TALENT GIRONÍ 2024- (execució nov24- jul25)

Codi oficial: TALENT GIRONÍ 2024 Data inicio:01/11/2024 Data fi: 31/07/2025 Investigador/a principal: ROSER FORT CULILLAS, CARLOS MOLINER ABÓS, HELENA PLA JUHER

Publicacions

Pla H, Felip E, Obadia V, Pernas S, Viñas G, Margelí M, Fort-Culillas R, Del Barco S, Sabaté N, Fort E, Lezcano C, Cirauqui B, Quiroga V, Stradella A, Gil Gil M, Esteve A, Recalde S

Elderly patients with hormone receptor-positive HER2-negative metastatic breast cancer treated with CDK4/6 inhibitors in a multicentre cohort

CLINICAL & TRANSLATIONAL ONCOLOGY, 2024, 26, 1748-1758 dx.doi.org/10.1007/s12094-024-03399-3
Plaja A, Teruel I, Ochoa-de-Olza M, Cucurull M, Arroyo ÁJ, Pardo B, Ortiz I, Gil-Martin M, Piulats JM, Pla H, Fina C, Carbó A, Barretina-Ginesta MP, Martínez-Román S, Carballas E, González A, Esteve A, Romeo M

Prognostic Role of Neutrophil, Monocyte and Platelet to Lymphocyte Ratios in Advanced Ovarian Cancer According to the Time of Debulking Surgery

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 dx.doi.org/10.3390/ijms241411420
Pla-Juher H, Pardo M, Izquierdo ÀJ, Darder E, Carbó A, Munté E, Torres-Esquius S, Balmaña J, Lázaro C, Brunet JM, Barretina-Ginesta MP

Risk of endometrial cancer after RRSO in BRCA 1/2 carriers: a multicentre cohort study.

CLINICAL & TRANSLATIONAL ONCOLOGY, 2023, 26, 1033-1037 dx.doi.org/10.1007/s12094-023-03312-4
Carbó-Bagué A, Fort-Culillas R, Pla-Juher H, Rubió-Casadevall J

Nivolumab-Induced Autoimmune Haemolytic Anaemia and Safety of Subsequent Use of Ipilimumab: A Case Report

Case Reports in Oncology, 2021, 14, 1289-1294 dx.doi.org/10.1159/000518530
Garrigós L, Saura C, Martinez-Vila C, Zambelli A, Bower M, Pistilli B, Lambertini M, Ottaviani D, Diamantis N, Lumsden A, Pernas S, Generali D, Seguí E, Viñas G, Felip E, Sanchez A, Rizzo G, Santoro A, Cortellini A, Perone Y, Chester J, Iglesias M, Betti M, Vincenzi B, Libertini M, Mazzoni F, Zoratto F, Berardi R, Guida A, Wuerstlein R, Loizidou A, Sharkey R, Aguilar Company J, Matas M, Saggia C, Chiudinelli L, Colomba-Blameble E, Galazi M, Mukherjee U, Van Hemelrijck M, Marin M, Strina C, Prat A, Pla H, Ciruelos EM, Bertuzzi A, Del Mastro L, Porzio G, Newsom-Davis T, Ruiz I, Delany MB, Krengli M, Fotia V, Viansone A, Chopra N, Romeo M, Salazar R, Perez I, d'Avanzo F, Franchi M, Milani M, Pommeret F, Tucci M, Pedrazzoli P, Harbeck N, Ferrante D, Pinato DJ, Gennari A

COVID-19 in breast cancer patients: a subanalysis of the OnCovid registry

THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2021, 13 dx.doi.org/10.1177/17588359211053416
Roca-Barceló A, Viñas G, Pla H, Carbó A, Comas R, Izquierdo A, Pinheiro PS, Vilardell L, Solans M, Marcos-Gragera R

Mortality of women with ductal carcinoma in situ of the breast: a population-based study from the Girona province, Spain (1994-2013)

CLINICAL & TRANSLATIONAL ONCOLOGY, 2019, 21, 891-899 dx.doi.org/10.1007/s12094-018-1994-1

Formulari de contacte

Conoce el IDIBGI!

 menu